Delcath Systems DCTH Foreign — Product revenue

Similar metrics at other companies

GCTProduct revenues — Revenue

$290.82M+28.9%

ITRIProduct revenues — Revenue

$453.46M-12.3%

CORTHypercortisolism Products — Product revenue, net

$208.58M+7.3%

SNDXNet Product Revenues — Revenue

$31.21M+1,526%

QTRXProduct revenue — Total revenues

$23.48M+39.5%

WHDProduct revenue — Total revenues

$297.24M+42.2%

FAQ

What is Delcath Systems's foreign — product revenue?

Delcath Systems (DCTH) reported foreign — product revenue of $1.97M in Q2 2026.

How has Delcath Systems's foreign — product revenue changed year-over-year?

Delcath Systems's foreign — product revenue increased by 19.1% year-over-year, from $1.66M to $1.97M.

What does foreign — product revenue mean?

This metric represents the total gross sales generated from the sale of pharmaceutical products and associated medical delivery systems within international markets outside of the company's primary domestic region. It serves as a key indicator of the company's global commercial expansion and the adoption rate of its specialized oncology therapies in foreign healthcare systems. Monitoring this figure helps investors assess the effectiveness of international distribution strategies and the scalability of the product portfolio across diverse regulatory environments.